MARK OLDAKOWSKI - 14 Mar 2025 Form 4 Insider Report for Bionano Genomics, Inc. (BNGO)

Role
Chief Operating Officer
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
Issuer symbol
BNGO
Transactions as of
14 Mar 2025
Transactions value $
$0
Form type
4
Filing time
18 Mar 2025, 18:45:26 UTC
Previous filing
19 Feb 2025
Next filing
03 Jun 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BNGO Stock Option (Right to Buy) Award $0 +6,966 $0 6,966 14 Mar 2025 Common Stock 6,966 $3.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each option award vests as follows: the shares subject to the option vest monthly over 48 months beginning on the one-month anniversary of the vesting commencement date, such that the option shall be fully vested and exercisable on the four-year anniversary of the vesting commencement date.